Genascence Corporation
PrivateLast Round
Grant
Feb 23, 2023
Total Funding Raised
$22.1M
Company Overview
Genascence Corporation is a biotechnology company developing gene therapies for prevalent musculoskeletal and joint diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genascence Corporation Comparables
Compare Genascence Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ICM Co., Ltd. | 83% | |
| Xalud Therapeutics | 83% | |
| Kolon TissueGene, Inc. | 82% | |
Genascence Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 23, 2023 | ||||
| Series A | May 10, 2022 |
Key People
Founding team and executive leadership
Genascence Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DeepWork Capital | Series A |
| California Institute for Regenerative Medicine | Grant |
| University of Florida Research Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2023
$12M grant received from California Institute for Regenerative Medicine.
Genascence Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genascence Corporation's valuation, stock price, and market status.